Divi's Laboratories Limited

DIVISLAB

INE361B01024

Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.

Sector

Pharmaceuticals

Calendar

01/08/2024 - Détachement de for final dividend

Related indices

NIFTY 50 , NIFTY 100

More about the company

Income Statement Evolution

More financial data

Ratings for Divi's Laboratories Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4,589 INR

Average target price

3,871 INR

Spread / Average Target

-15.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DIVI'S LABORATORIES LIMITED	+17.54%	14.58B
ELI LILLY AND COMPANY	+51.91%	791B
NOVO NORDISK A/S	+40.45%	630B
MERCK & CO., INC.	+16.88%	328B
ABBVIE INC.	+9.29%	298B
ASTRAZENECA PLC	+17.25%	246B
ROCHE HOLDING AG	+0.41%	225B
NOVARTIS AG	+10.22%	218B
AMGEN INC.	+5.27%	160B
PFIZER, INC.	-6.48%	156B

Other Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 12:43:53 14/06/2024 BST			5-day change	1st Jan Change
4,589 ^INR	-0.11%		+1.43%	+17.54%

06-13	Indian Equities End Higher, Buoyed by Positive Global Cues Due to US Inflation Data	MT
05-31	Indian Equities Close with Mild Gains on Friday, Helped by Financial, Telecom Stocks	MT

Indian Equities End Higher, Buoyed by Positive Global Cues Due to US Inflation Data	06-13	MT
Indian Equities Close with Mild Gains on Friday, Helped by Financial, Telecom Stocks	05-31	MT
Indian Equities Dragged Down by Losses in Financial, IT Stocks	05-29	MT
Indian Equities Extend Losing Run to Third Day Amid Poll Worries	05-28	MT
INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher	05-28	RE
INDIA STOCKS-Metal stocks lead Indian shares higher	05-28	RE
Profit Booking Drags Indian Equities to End with Marginal Losses on Monday	05-27	MT
Jefferies Adjusts Divi’s Laboratories Price Target to INR4,050 From INR3,610, Keeps at Hold	05-27	MT
INDIA STOCKS-Indian shares ease off record highs as volatility stays elevated	05-27	RE
Divi's Laboratories' Consolidated Profit Jumps in Fiscal Q4; Shares Climb 3%	05-27	MT
INDIA STOCKS-Indian shares at record highs, boosted by pharma stocks, Adani Ports	05-27	RE
Transcript : Divi's Laboratories Limited, Q4 2024 Earnings Call, May 25, 2024	05-25
Divi's Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-25	CI
Divi's Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-25	CI
Divi's Laboratories Limited Recommends A Final Dividend for the Financial Year 2023-24	05-25	CI
Weak March Quarter Earnings Weigh Down Indian Equities on Friday	04-26	MT
Divi's Laboratories Plans Up To INR7 Billion Investment to Boost Capacity	04-25	MT
Indian Equities Close Higher on Friday, Led by Metal, Banking Stocks	04-19	MT
Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade	04-12	MT
Indian Equities End Higher on Wednesday, Lifted Mainly by Metal Stocks	04-10	MT
Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)	04-05	CI
Indian Equities Close with Marginal Loss on Wednesday as Traders Scale Down Hopes on US Rate Cuts	04-03	MT
Indian Equities End Higher on Monday, Led by Gains in Metal, Realty Stocks	04-01	MT
Indian Equities Close Lower on Monday, Draagged by Major Banking, Financial Companies	02-12	MT
INDIA STOCKS-Energy shares drag India's blue-chip stocks; small, mid-caps slide	02-12	RE